Phenylethylmalonamide in essential tremor. A double-blind controlled study.
A randomised double-blind placebo-controlled trial of phenylethylmalonamide, the major metabolite of primidone was performed in eight patients with essential tremor. Phenylethylmalonamide was given in a daily dose of 400 mg for one week and 800 mg for a second week. The compound had no statistically...
保存先:
| 出版年: | J Neurol Neurosurg Psychiatry |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
1981
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC491180/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7031184/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.44.10.932 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|